These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 4016794

  • 21. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

  • 22. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB, Tong WP, Chou TC.
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [Abstract] [Full Text] [Related]

  • 23. Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts.
    Snyder RD, Malick NC.
    Mol Pharmacol; 1985 Dec; 28(6):574-80. PubMed ID: 4079913
    [Abstract] [Full Text] [Related]

  • 24. Interaction of arabinosyl nucleotides in K562 human leukemia cells.
    Gandhi V, Plunkett W.
    Biochem Pharmacol; 1989 Oct 15; 38(20):3551-8. PubMed ID: 2479383
    [Abstract] [Full Text] [Related]

  • 25. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Plunkett W, Dixon DO.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5952-7. PubMed ID: 4053067
    [Abstract] [Full Text] [Related]

  • 26. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
    Boos J, Hohenlöchter B, Schulze-Westhoff P, Schiller M, Zimmermann M, Creutzig U, Ritter J, Jurgens H.
    Med Pediatr Oncol; 1996 Jun 15; 26(6):397-404. PubMed ID: 8614376
    [Abstract] [Full Text] [Related]

  • 27. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 28. Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine.
    Capizzi RL, White JC, Powell BL, Perrino F.
    Semin Hematol; 1991 Jul 15; 28(3 Suppl 4):54-69. PubMed ID: 1780754
    [Abstract] [Full Text] [Related]

  • 29. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Verhoef V, Fridland A.
    Cancer Res; 1985 Aug 15; 45(8):3646-50. PubMed ID: 2410098
    [Abstract] [Full Text] [Related]

  • 30. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1780-6. PubMed ID: 19428333
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P, Lien EJ, Avramis VI.
    Anticancer Res; 1999 Jun 15; 19(3A):1625-33. PubMed ID: 10470093
    [Abstract] [Full Text] [Related]

  • 32. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
    Gandhi V, Xu YZ, Estey E.
    Clin Cancer Res; 1998 Jul 15; 4(7):1719-26. PubMed ID: 9676847
    [Abstract] [Full Text] [Related]

  • 33. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ, Colly LP, Arkesteijn GJ, Arentsen-Honders MW, Kerster MG, ter Riet PM, Willemze R.
    Cancer Res; 1990 Oct 15; 50(20):6515-9. PubMed ID: 2208110
    [Abstract] [Full Text] [Related]

  • 34. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism by thymidine in human acute leukemia.
    Zittoun R, Zittoun J, Marquet J, Rustum Y, Creaven P.
    Cancer Res; 1985 Oct 15; 45(10):5186-92. PubMed ID: 4027995
    [Abstract] [Full Text] [Related]

  • 35. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT, Craig RW, Agarwal RP.
    Cancer Res; 1980 Sep 15; 40(9):3286-92. PubMed ID: 7427943
    [Abstract] [Full Text] [Related]

  • 36. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
    Raymakers RA, Slocum HK, Minderman H, Malmberg M, Rustum YM.
    Exp Hematol; 1993 May 15; 21(5):602-7. PubMed ID: 8513859
    [Abstract] [Full Text] [Related]

  • 37. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
    Ross DD, Joneckis CC, Song TH, Wu RK.
    Cancer Res; 1988 Feb 01; 48(3):517-21. PubMed ID: 3335018
    [Abstract] [Full Text] [Related]

  • 38. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Chemother Pharmacol; 1992 Feb 01; 31(1):11-7. PubMed ID: 1458554
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
    White JC, Hines LH, Rathmell JP.
    Cancer Res; 1985 Jul 01; 45(7):3070-5. PubMed ID: 4005845
    [Abstract] [Full Text] [Related]

  • 40. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Cancer Res; 1984 Nov 01; 44(11):5046-50. PubMed ID: 6488163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.